Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
BondTrue
AddedFeb 18, 2024
UpdatedJun 18, 2026
BondTrue

BondTrue

Angel

BondTrue LLC, a medical device firm, innovates surgical procedures with automated incision and closure technology.

HQ
Baltimore, MD, US
Founded
2016
Overview
Compare
Fundraising
Employees
Website

BondTrue LLC, founded with the mission to revolutionize surgical procedures, focuses on developing automated incision and closure technology. The company aims to enhance surgical precision and efficiency through its patented device (#9,408,672). Their core product is designed to automate the process of surgical incisions and closures, targeting the medical device market with a particular emphasis on improving outcomes in surgical settings.

Notable affiliations include funding from the National Science Foundation and Maryland Industrial Partnerships (MIPS) of the Maryland Technology Enterprise Institute. BondTrue has received a Phase II MIPS award worth $100,000 and is a TEDCO Portfolio Company. Key achievements include winning the ExportMD grant and being featured in The Baltimore Business Journal. BondTrue's innovations have made significant impacts in the medical device industry, particularly in enhancing surgical automation and precision.

BondTrue - Similar Companies

EndoEvolution logo

EndoEvolution

Bond-Pro logo

Bond-Pro

bond-pro.com

Buck Surgical logo

Buck Surgical

bucksurgical.com

Opus KSD logo

Opus KSD

subq-it.com

Surgical Automations logo

Surgical Automations

autosurg.com

Encision logo

Encision

Bedrock Surgical logo

Bedrock Surgical

Surgimatix logo

Surgimatix

surgimatix.com

Clozex Medical logo

Clozex Medical

clozex.com

Incisive Surgical logo

Incisive Surgical

insorb.com

DuraStat logo

DuraStat

durastat.com

SeeTrue Technology logo

SeeTrue Technology

Dualflo logo

Dualflo

Surgrx logo

Surgrx

Prescient Surgical logo

Prescient Surgical

BondTrue - Quick Facts

Who are BondTrue's competitors?

Companies similar to BondTrue include EndoEvolution, Bond-Pro, Buck Surgical and Opus KSD.

When was BondTrue founded?

BondTrue was founded in 2016.

Where is BondTrue's headquarters located?

BondTrue's headquarters is located in Baltimore, MD, US.

When was BondTrue's last funding round?

BondTrue's most recent funding round was for $256k (USD) in March 2021.

How much has BondTrue raised to-date?

As of Mar 30, 2021, BondTrue has raised a total of $532k (USD).

How many employees does BondTrue have?

BondTrue has 6 employees as of Feb 4, 2024.

BondTrue - Classification

Industry
  • Hardware
Ownership
  • Government
  • Private
  • Venture Capital
Technology
  • Automation
  • Robotics
Geographic Exposure
  • United States
Revenue
  • Transactional
Customer
  • Enterprise
  • Government
Main Product
  • Medical Devices
  • Surgical Devices
Tags
  • Healthtech
  • Medical Device
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified